Properdin deficiency: Molecular basis and disease association

Molecular Immunology

Volumn 36, Issue 13-14, 1999, Pages 863-867

  Fijen, C A P ^a   Van Den Bogaard, R ^a   Schipper, M ^a   Mannens, M ^a   Schlesinger, M ^b   Nordin, Fredrikson G ^c   Dankert, J ^a   Daha, M R ^d   Sjoholm A G ^e   Truedsson, L ^e   Kuijper, E J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b BARZILAI MEDICAL CENTER   (Israel)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d LEIDEN UNIVERSITY   (Netherlands)

^e LUND UNIVERSITY   (Sweden)

Author keywords

Alternative pathway; Complement; Meningococci; Neisseria meningitidis; Properdin

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; PROPERDIN;

BINDING SITE; COMPLEMENT ACTIVATION; COMPLEMENT DEFICIENCY; CONFERENCE PAPER; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; MOLECULAR GENETICS; MULTIGENE FAMILY; NEISSERIA MENINGITIDIS; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN STABILITY;

AMINO ACID SEQUENCE; COMPLEMENT PATHWAY, ALTERNATIVE; HUMANS; MENINGOCOCCAL INFECTIONS; MOLECULAR SEQUENCE DATA; MUTATION; PHENOTYPE; PROPERDIN; REPETITIVE SEQUENCES, AMINO ACID;

EID: 0033368616     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(99)00107-8     Document Type: Conference Paper

References (31)

1. van den Bogaard, R., Fijen, C.A.P., Schipper, M., de Galan, L., Kuijper, E.J., Mannens, M., 1999. Molecular Characterisation of 10 Dutch Properdin Type 1 Deficient Families; Mutation Analysis and X-inactivation Studies. Eur. J. Hum. Gen., In press.
2. Brandtzaeg P., Høgåsen K., Kierulf P., Mollnes T.E. The excessive complement activation in fulminant meningococcal septicemia is predominantly caused by alternative pathway activation. J. Infect. Dis. 173:1996;647-655.
3. Coleman M.P., Willard J.C., Nolan K.F., Reid K.B.M., Blake D.J., Lindsay S., Bhattacharya S.S., Wright A., Davies K.E. Genetic and physical mapping around the P gene. Genomics. 11:1991;991-996.
4. Cunliffe N.A., Snowden N., Dunbar E.M., Haeney M.R. Recurrent meningococcal septicaemia and properdin deficiency. J. Infect. 31:1995;67-68.
5. Fearon D.T., Austen K.F. Properdin: binding of C3 and stabilization of the C3b-dependent C3 convertase. J. Exp. Med. 142:1975;856-863.
6. Figueroa J.E., Densen P. Infectious diseases associated with complement deficiencies. Clin. Microbiol. Rev. 4:1991;359-395.
7. Fijen C.A.P., van den Bogaard R., Daha M.R., Dankert J., Mannens M., Kuijper E.J. Carrier detection by microsatellite haplotyping in 10 properdin type 1 deficient families. Eur. J. Clin. Invest. 26:1996;902-906.
8. Fijen C.A.P., Kuijper E.J., te Bulte M.T., Daha M.R., Dankert J. Assessment of complement deficiency in patients with meningococcal disease in the Netherlands. Clin. Infect. Dis. 28:1999;98-105.
9. Fijen, C.A.P., Bredius, R.G.M., Kuijper, E.J., Out, T.A., de Haas, M., de Wit, A.P.M., Daha, M.R., Dankert, J., van de Winkel, J.G.J., 1999b. Complement Deficiency and the Role of Fcγ Receptors, Properdin and C3 in Phagocytosis of Meningococci. Clin. Exp. Immunol., accepted.
10. Götze O., Müller-Eberhard H.J. The C3 activation system: an alternative pathway of complement activation. J. Exp. Med. 134:1971;90s-108s.
11. Goundis D., Reid K.B.M. Properdin, the terminal complement components, thrombospondin and the circumsporozoite protein of malaria parasites contain similar sequence motifs. Nature. 335:1988;82-85.
12. Higgins J.M.G., Wiedemann H., Timpl R., Reid K.B.M. Characterization of mutant forms of recombinant human properdin lacking single thrombospondin type 1 repeats. J. Immunol. 155:1995;5777-5785.
13. Jarvis G.A. Recognition and control of neisserial infection by antibody and complement. Trends in Microbiol. 3:1995;198-201.
14. Nielsen H.E., Koch C., Magnussen P., Lind I. Complement deficiencies in selected groups of patients with meningococcal disease. Scand. J. Infect. Dis. 21:1989;389-396.
15. Nielsen H.E., Koch C., Mansa B., Magnussen P., Bergmann O. Complement and immunoglobulin studies in 15 cases of chronic meningococcaemia: properdin deficiency and hypoimmunoglobulinaemia. Scand. J. Infect. Dis. 22:1990;31-36.
16. Nolan K.F. Complete primary structure of human properdin: a positive regulator of the alternative pathway of the serum complement system. Bioch. Soc. Trans. 18:1990;1161-1162.
17. Nolan K.F., Kaluz S., Higgins J.G.M., Goundis D., Reid K.B.M. Characterisation of the human properdin gene. Biochem. J. 287:1992;291-297.
18. Nordin Fredrikson G., Westberg J., Uhlén M., Sjöholm A.G., Truedsson L. Type 1 human properdin deficiency: a point mutation in exon five generates a stop codon. Clin. Exp. Immunol. 97:1994;37. S2.
19. Nordin Fredrikson G., Westberg J., Kuijper E.J., Tijssen C.C., Sjöholm A.G., Uhlén M., Truedsson L. Molecular characterization of properdin deficiency type III: dysfunction produced by a single point mutation in exon 9 of the structural gene causing a tyrosine to aspartic acid interchange. J. Immunol. 157:1996;3666-3671.
20. Nordin Fredrikson G., Gullstrand B., Westberg J., Sjöholm A.G., Uhlén M., Truedsson L. Expression of properdin in complete and incomplete deficiencies: normal in vitro synthesis in two cases with properdin deficiency type II due to distinct mutations. J. Clin. Immunol. 18:1998;272-282.
21. Pangburn M.K. Analysis of the natural polymeric forms of human properdin and their functions in complement activation. J. Immunology. 142:1989;202-207.
22. Pillemer L., Blum L., Lepow I.H., Ross O.A., Todd E.W., Wardlaw A.C. The properdin system and immunity: demonstration and isolation of a new serum protein, properdin and its role in immune phenomena. Science. 120:1954;279-285.
23. Schlesinger M., Mashal U., Levy J., Fishelson Z. Hereditary properdin deficiency in three families of Tunesian Jews. Acta Paediatr. 82:1993;744-747.
24. Sjöholm A.G., Braconier J.-H., Söderström C. Properdin deficiency in a family with fulminant meningococcal infections. Clin. Exp. Immunol. 50:1982;291-297.
25. Sjöholm A.G., Söderström C., Nilsson L.A. A second variant of properdin deficiency: the detection of properdin at low concentrations in affected males. Complement. 5:1988;130-140.
26. Sjöholm A.G., Kuijper E.J., Tijssen C.C., Jansz A., Bol P., Spanjaard L., Zanen H.C. Dysfunctional properdin in a Dutch family with meningococcal disease. N. Engl. J. Med. 319:1988;33-37.
27. Sjöholm A.G. Inherited complement deficiency states: implications for immunity and immunological disease. Acta Pathol. Microbiol. Immunol. Scand. 98:1990;861-874.
28. Späth, P.J., Sjöholm, A.G., Nordin, Frederikson G., Misiano, G., Rohner, R., Schaad, U.B., Uhring-Lambert, B., Hauptmann, G., Westberg, J., Uhlén, M., Wadelius, C., Truedsson, L., 1999. Properdin Deficiency in a Large Swiss Family: Identification of a Stop Codon in the Properdin Gene, and Association of Meningococcal Disease with Lack of the IgG2 Allotype Marker G2m(n). Clin. Exp. Immunol., in press.
29. Truedsson L., Westberg J., Nordin Fredrikson G., Sjöholm A.G., Kuijper E.J., Fijen C.A.P., Späth P.J., Uhlén M. Human properdin deficiency has a heterogeneous genetic background. Immunopharmacology. 38:1997;203-206.
30. Westberg J., Nordin Frederikson G., Truedsson L., Sjöholm A.G., Uhlén M. Sequence-based analysis of properdin deficiency: identification of point mutations in two phenotypic forms of an X-linked immunodeficiency. Genomics. 29:1995;1-8.
31. Whiteman L.Y., Purkall D.B., Ruddy S. Covalent linkage of C3 to properdin during complement activation. Eur. J. Immunol. 25:1995;1481-1484.